PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $27,000 | +8.0% | 11,910 | -14.4% | 0.00% | 0.0% |
Q4 2016 | $25,000 | -35.9% | 13,910 | +7.7% | 0.00% | -50.0% |
Q3 2016 | $39,000 | +5.4% | 12,910 | +8.4% | 0.00% | 0.0% |
Q2 2016 | $37,000 | -5.1% | 11,910 | 0.0% | 0.00% | -33.3% |
Q1 2016 | $39,000 | +62.5% | 11,910 | +65.2% | 0.00% | +200.0% |
Q4 2015 | $24,000 | – | 7,210 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KESTREL INVESTMENT MANAGEMENT CORP | 1,585,500 | $3,710,000 | 1.36% |
SMH CAPITAL ADVISORS INC | 83,369 | $195,000 | 0.32% |
West Family Investments, Inc. | 338,141 | $791,000 | 0.20% |
Matarin Capital Management, LLC | 927,289 | $2,169,856,000 | 0.16% |
ROCKY MOUNTAIN ADVISERS, LLC | 14,300 | $33,000 | 0.12% |
Alambic Investment Management, L.P. | 163,200 | $382,000 | 0.10% |
KENNEDY CAPITAL MANAGEMENT LLC | 1,760,376 | $4,119,000 | 0.08% |
Connor, Clark & Lunn Investment Management Ltd. | 5,677,647 | $13,286,000 | 0.08% |
Zebra Capital Management LLC | 67,892 | $159,000 | 0.07% |
Fortis Advisors, LLC | 45,602 | $107,000 | 0.06% |